In the new area of noninvasive markers of hepatocellular carcinoma

Journal of Hepatology

Volumn 46, Issue 1, 2007, Pages 9-11

  Paradis, Valérie ^a   Bedossa, Pierre ^a  

^a BEAUJON HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; AUTOANTIBODY; CELL PROTEIN; NUCLEIC ACID; TUMOR ANTIGEN; TUMOR MARKER;

CANCER DIAGNOSIS; CANCER IMMUNOLOGY; CARCINOGENESIS; CHRONIC LIVER DISEASE; DISEASE MARKER; EDITORIAL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEOMICS; SENSITIVITY AND SPECIFICITY;

ANTIGENS, NEOPLASM; CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER NEOPLASMS; PROTEOMICS; TUMOR MARKERS, BIOLOGICAL;

EID: 34848906365     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2006.10.006     Document Type: Editorial

References (17)

1. Imbert-Bismuth F., Ratziu V., Pieroni L., Charlotte F., Benhamou Y., and Poynard T. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 357 (2001) 1069-1075
2. Cales P., Oberti F., Michalak S., Hubert-Fouchard I., Rousselet M.C., Konate A., et al. A novel panel of blood markers to assess the degree of liver fibrosis. Hepatology 42 (2005) 1373-1381
3. Snyder N., Gajula L., Xiao S.Y., Grady J., Luxon B., Lau D.T., et al. APRI: an easy and validated predictor of hepatic fibrosis in chronic hepatitis C. J Clin Gastroenterol 40 (2006) 535-542
4. Bruix J., and Sherman M. Management of hepatocellular carcinoma. Hepatology 42 (2005) 1208-1236
5. Sahin U., Tureci O., Schmitt H., et al. Human neoplasms elicit multiple specific immune responses in the autologous host. Proc Natl Acad Sci USA 92 (1995) 11810-11813
6. Minenkova O., Pucci A., Pavoni E., De Tomassi A., Fortugno P., Gargano N., et al. Identification of tumor-associated antigens by screening phage-displayed human cDNA libraries with sera from tumor patients. Int J Cancer 106 (2003) 534-544
7. Zhang J.-Y., Megliorino R., Peng X.-X., Tan E.M., Chen Y., and Chan E.K.L. Antibody detection using tumor-associated antigen mini-array in immunodiagnosing human hepatocellular carcinoma. J Hepatol 46 (2007) 107-114
8. Winter S.F., Minna J.D., Jonhson B.E., Takahashi T., Gazdar A.F., and Carbone D.P. Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutations. Cancer Res 52 (1992) 4168-4174
9. Davidoff A.M., Iglehart J.D., and Marks J.R. Immune response to p53 is dependent upon p53/HSP70 cpmoplexes in breast cancers. Proc Natl Acad Sci USA 89 (1992) 3439-3942
10. Wang X., Yu J., Sreekumar A., Varambally S., Shen R., Giachero D., et al. Autoantibody signatures in prostate cancer. New Eng J Med 353 (2005) 1224-1235
11. Koziol J.A., Zhang J.-H., Casiano C.A., Peng X.-X., Shi F.-D., Feng A.C., et al. Recursive partitioning as an approach to selection of immune markers for tumor diagnosis. Clin Cancer Res 9 (2003) 5120-5126
12. Imai H., Nakano Y., Kiyosawa K., and Tan E.M. Increasing titers and changing specificities of antinuclear antibodies in patients with chronic liver disease who develop hepatocellular carcinoma. Cancer 71 (1993) 26-35
13. Steel L.F., Shumpert D., Trotter M., Seeholzer S.H., Evans A.A., London W.T., et al. A strategy for rhe comparative analysis of serum proteomes for the discovery of biomarkers for hepatocellular carcinoma. Proteomics 3 (2003) 601-609
14. Poon T.C.W., Yip T.-T., Chan A.T.C., Yip C., Yip V., Mok T.S.K., et al. Comprehensive proteomic profiling identifies serum proteomic signatures for detection of hepatocellular carcinoma and its subtypes. Clin Chem 49 (2003) 752-760
15. Paradis V., Degos F., Dargère D., Pham N., Belghiti J., Degott C., et al. Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver diseases. Hepatology 41 (2005) 40-47
16. Schwegler E.E., Cazares L., Steel L.F., Adam B.-L., Jonhson D.A., Semmes O.J., et al. SELDI-TOF MS profiling of serum for detection of the progression of chronic hepatitis C to hepatocellular carcinoma. Hepatology 41 (2005) 634-642
17. Le Naour F., Brichory F., Misek D.E., Bréchot C., Hanash S.M., and Beretta L. A distinct repertoire of autoantibodies in hepatocellular carcinoma identified by proteomic analysis. Mol Cell Proteomics 1 (2002) 197-203